VivoSeq
Other

Bone Loss

0

Pipeline Programs

2

Active Trials

0

Companies Involved

Bone Loss is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

12

clinical trials

Completed8 · 67%
Unknown status2 · 17%
Recruiting1 · 8%
Not yet recruiting1 · 8%

Trial Activity

12 trials

Effects of Low-Dose Doxycycline on Oral Bone Loss
Completed·UUniversity of Nebraska·Phase 3·NCT00066027·128 enrolled
Magnesium Supplementation to Prevent Bone Loss
Completed·UUniversity of Tennessee·Phase 1·NCT00346658·74 enrolled
Simvastatin to Prevent SCI-Induced Bone Loss
Unknown status··Phase 2·NCT02946424·76 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)